Miglustat - Actelion Pharmaceuticals
At a glance
- Drug Originator Oxford Glycobiology Institute
- Drug Licenced by Actelion Pharmaceuticals; Knight Therapeutics; Teva Pharmaceutical Industries; United Therapeutics Corporation
- Drug Class Alkaloids; Imino pyranoses; Small molecules
- Mechanism of Action Alpha-glucosidase inhibitors; Glucosylceramide synthase inhibitors
- USA Patent Applicants ACTELION
- USA Patents 2
- NDAs 1
- Patent Applications 2,229
Table of Contents
Disclaimer